CDN Maverick Capital Corp. (CSE:CDN) Announces Normal Course Issuer Bid

Vancouver, British Columbia — January 17, 2026 — Leads & Copy — CDN Maverick Capital Corp. (CSE: CDN) (OTCQB: AXVEF) (FSE: 338B) (“Maverick” or the “Company”) has announced the implementation of a normal course issuer bid (“NCIB”) to purchase up to 1,048,061 of its common shares, representing approximately 5% of the Company’s issued and outstanding shares.

The Company may purchase shares under the NCIB over 12 months beginning on January 19, 2026, and ending no later than January 18, 2027. According to the company, all Shares purchased under the NCIB will be purchased on the open market through the facilities of the CSE or Canadian alternative trading systems at the prevailing market price of the Shares at the time of purchase and in accordance with the policies of the CSE and applicable Canadian securities laws.

The company said that all Shares purchased under the NCIB will be cancelled and the purchases of Shares under the NCIB will be funded with cash on hand. The exact timing and amount of any purchases of Shares made pursuant to the NCIB will depend on market conditions and other factors.

Maverick also noted that it has no obligation to acquire any Shares and may suspend or discontinue purchases under the NCIB at any time. The actual number of Shares which may be purchased under the NCIB and the timing of any such purchases will be determined by management of the Company, subject to applicable laws and the rules of the CSE.

Under the NCIB, the Company may purchase on the CSE up to a number of Shares equal to 2% of its issued and outstanding Shares over any 30-trading-day period. Haywood Securities Inc. will conduct the NCIB transactions on behalf of the Company.

The Board of Directors of Maverick believes that the Shares have been trading in a price range that does not adequately reflect the value of the Company’s business and prospects. Therefore, purchasing Shares for cancellation is an appropriate strategy for increasing long-term shareholder value. To the knowledge of the Company, no director, senior officer or other insider of the Corporation currently intends to sell any shares under the NCIB. The Corporation has not repurchased any of its Shares on the CSE or otherwise in the previous 12 months.

CDN Maverick Capital Corp. (CSE: CDN) is a project generator and critical minerals exploration company focused on identifying and developing high-value assets using data-driven exploration strategies. The Company is advancing a portfolio of lithium and battery metals projects across tier-one mining jurisdictions in North America.

For further information, contact:

CDN Maverick Capital Corp.
Suite 2150 – 555 West Hastings Street
Vancouver, BC, Canada, V6B 4N6

Sandy MacDougall
Founder, Chairman, and Director
sandyjmacdougall@gmail.com
C: +1 778 999 2159

Simon Studer
Interim CEO and Director
simondavidstuder@gmail.com
Phone: 0041 44 585 24 84

Source: CDN Maverick Capital Corp.

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.